Sage Journals: Discover world-class research

Abstract

Present study evaluates efficacy of Trifala and Ela as plaque controlling agent and compares it with chlorhexidine.

Aim.

To evaluate Antigingivitis, Antiplaque and Antihalitosis effect of Triphala and Ela decoction. A randomized sample of 60 patients with plaque induced gingivitis was enrolled and equally divided into two groups group A and group B. Group A was given Trifala and Ela decoction and Group B Chlorehexidine mouthwash for 21 days twice daily. Gingival inflammation index, plaque index and Organoleptic scoring scale was recorded at baseline, 14th day and 21st day. Comparing the plaque index for Group A with group B the reduction in from baseline to 14 day was 42.59 % and 38.62% respectively while from baseline to 21 day was 56.20% and 68.57% respectively. On comparing Gingival index for group A with group B the reduction from baseline to 14 day was 31.95% and 38.62 % respectively while from baseline to 21 day was 69.95 % and 68.57% respectively. Halitosis Percentage reduction at 14th day from base line was 33.33% and 38.18%; at 21 day from baseline 66.66% and 72.72% respectively for group A and group B. No statistical significant difference for intergroup comparison was found using paired t test. Intra group analysis using unpaired t test was significant for all the indices at different time intervals. Triphala and Ela decoction is organic, easy to prepare economical and equally effective as compared to chlorhexidine mouthwash.

Keywords

antigingivitis antiplaque halitosis triphala Ela plaque induced gingivitis

Ayurveda is an ancient Indian system of medicine that offers a vast pool of herbal medication effective and often considered free of toxicity of modern allopathic preparations. In recent times, a lot of clinical trials have been conducted, evaluating the age-old science of ayurveda by testing it against the gold standard allopathic preparations used for established treatment modalities.¹ Kaval (mouthwash) is described in ayurvedic text for the treatment of various oral and dental problems.

Gingivitis is one of the most prevalent oral diseases worldwide and is caused by the bacterial biofilm surrounding the teeth. Gingivitis leads to swollen gums, bleeding gums and halitosis.² all these conditions results in poor oral hygiene and a cascade of events causing early loss of teeth leading to dental aesthetics and function problems.

To control the 2 most challenging problems of oral cavity, namely, gingivitis and halitosis, an array of chemical agents have been employed in the past. Chlorhexidine is one such agent, which has stood the test of time and is considered a gold standard in chemical plaque control. Chlorhexidine is available as mouthwash, topical gel, and in biodegradable form. It has a broad-spectrum antimicrobial activity and is a cationic molecule, which causes bacterial cell wall lysis and rupture. Cationic molecules bind to the negatively charged surfaces such as teeth surface, dental pellicle, and bacterial cell wall. Chlorhexidine has a substantivity of 12 hours and hence is used twice daily.³

Triphala consists of equal parts of the Emblica officinalis, Terminalia chebula, and Terminalia belerica.⁴ Ela (Elettaria cardamomum), commonly known as green or true cardamom, is an herbaceous perennial plant in ginger family native to southern India. It is described as a digestive, aromatic, deodorant, fragrant, carminative herb and chewed to prevent unpleasant odor of oral cavity.⁵

The present clinical trial compares these 2 agents for their effectiveness in controlling plaque, gingivitis, and halitosis. This study explores use of herbal agent such as Triphala and Ela in combatting oral infections such as plaque-induced gingivitis. Aim of the present study is to evaluated efficacy of such herbal products and their effectiveness as a plaque-controlling agent.

Subjects and Methods

Sixty patients with plaque-induced gingivitis were enrolled, divided into 2 groups of 30 each by random computer allocation. Group A was given Triphala and Ela decoction for 21 days and group B was given chlorehexidine mouthwash for 21 days twice daily after cleaning the oral cavity with water. The decoction/ mouthwash was used for 60 seconds by vigorous swishing in mouth (mouth rinse). All the patients were kept on standardized oral hygiene protocol. Gingival index, plaque index, and organoleptic scoring scale were recorded at baseline, 14th day, and the 21st day.^6
–8

Statistical analysis was carried out using SPSS version 20.0 (SPSS, Inc, Somers, NY, USA). A comparison of the mean differences of the gingival and plaque indexes was done by a paired t test within the groups at different time intervals and unpaired t test was used when intergroup comparison was made. Level of significance was set at P ≤ .05 (95% confidence interval).

Informed consent was taken from the patients and ethical clearance was obtained by the ethical committee of Himalayan Institute of Medical Sciences vide letter no. HIHTU/HIMS/RC/2013/307. The study was conducted in accordance with Helsinki declaration.⁹

The inclusion criteria were the following:

Age >18 years

Systemically healthy

Plaque-induced gingivitis

Halitosis

The exclusion criteria were the following:

Mouthwash use in past 3 months

Antibiotic therapy in past 3 months

Orthodontic and prosthetic appliances use

Systemic disorders like diabetes mellitus, renal failure, and so on

Pregnancy

Smoking

Chemotherapy and radiotherapy

Patients with established periodontitis

Standard protocol followed for preparation of Triphala and Ela decoction under in-house pharmacy of Ayurvedic Center of Swami Rama Himalayan University under expert guidance of an ayurvedic physician.

All the 4 herbs were procured from the local market after proper identification. Coarse powder of Triphala and fine powder of Ela seeds was prepared at the Ayurvedic Centre, Himalayan Institute Hospital Trust. Triphala kwath was made as per Kwath prakarana of Ayurveda Sar Sangraha and 3 g Ela churna was mixed in 100 mL of Triphala.¹⁰ A commercial preparation of chlorhexidine—Chlorhex Plus mouthwash manufactured by Dr Reddys (batch no. BCP2067) was used.

Results

At baseline, there was no statistical difference between the 2 treatment options for gingival and plaque indexes.

Plaque Index

Both treatment groups reported significant reduction in plaque index from baseline. There was no significant statistical difference observed between the 2 treatment groups.

Triphala and Ela: Group A

The values of mean ± SD for plaque index at baseline, 14 days, and 21 days were 2.16 ± 0.324, 1.242 ± 0.246, and 0.946 ± 0.147, respectively (Table 1). There was a statistically significant difference in plaque index from baseline to 14 days and from baseline to 21 days.

Table 1.

Plaque Index and Gingival Index for Group A at Various Time Intervals.

	Baseline	14 Days	P (Baseline vs 14 Days)	21 Days	P (Baseline vs 21 Days)
Plaque index	2.16 ± 0.324	1.242 ± 0.246	.004	0.946 ± 0.147	<.001
Gingival index	1.784 ± 0.232	1.214 ± 0.163	.032	0.536 ± 0.124	<.001

Chlorhexidine group: Group B

The values of mean ± SD for plaque index at baseline, 14 days, and 21 days were 2.28 ± 0.154, 1.24 ± 0.152, and 0.916 ± 0.137, respectively (Table 1). There was a statistically significant difference in plaque index from baseline to 14 days and from baseline to 21 days. On comparison of plaque index for group a with group B, the reduction from baseline to 14 days was 42.59% and 38.62%, respectively, while from baseline to 21 days the reduction was 56.20% and 68.57%, respectively. This difference was statistically not significant (Figure 1; Table 2). Intergroup comparison of group A and group B for plaque index (mean ± SD) at baseline to 14 days was 0.92 ± 0.078 and 1.04 ± 0.002, respectively, while from baseline to 21 days, mean ± SD was 1.214 ±0.177 and 1.364 ± 0.017, respectively (Table 3).

Figure 1.

Plaque index (PI) of group A versus group B.

Table 2.

Percentage Reduction in Plaque Index (PI) and Gingival Index (GI) at Various Time Intervals.

Time	Triphala and Ela Group		Chlorhexidine Group		P
Time	PI	GI	PI	GI	P
0-14 days	42.59%	31.95%	45.61%	38.62%	.75
0-21 days	56.20%	69.95%	59.82%	68.57%	.86

Table 3.

Intergroup Comparison of Plaque Index (PI) and Gingival Index (GI) (Mean ± SD) at Various Time Intervals.

Time	Triphala and Ela Group		Chlorhexidine Group		P
Time	PI	GI	PI	GI	P
0-14 days	0.92 ± 0.078	0.57 ± 0.069	1.04 ± 0.002	0.73 ± 0.009	.94
0-21 days	1.214 ± 0.177	1.248 ± 0.108	1.364 ± 0.017	1.296 ± 0.02	.65

Gingival Index

Both treatment groups reported significant reduction in gingival index from baseline. There was no statistical significant difference observed between the 2 treatment groups.

Triphala and Ela Group: Group A

The values of mean ± SD for gingival index at baseline, 14 days, and 21 days were 1.784 ± 0.232, 1.214 ± 0.163, and 0.536 ± 0.124, respectively (Table 4). There was a statistically significant difference in gingival index from baseline to 14 days and from baseline to 21 days.

Table 4.

Plaque Index and Gingival Index for Group B at Various Time Intervals.

	Baseline	14 Days	P (Baseline vs 14 Days)	21 Days	P (Baseline vs 21 Days)
Plaque index	2.28 ± 0.154	1.24 ± 0.152	.002	0.916 ± 0.137	<.001
Gingival index	1.89 ± 0.138	1.16 ± 0.129	<.001	0.594 ± 0.163	<.001

Chlorhexidine Group: Group B

The values of mean ± SD for gingival index at baseline, 14 days, and 21 days were 1.89 ± 0.138, 1.16 ± 0.129, and 0.594 ± 0.163, respectively (Table 4). There was a statistically significant difference in gingival index from baseline to 14 days and from baseline to 21 days.

On comparison of group A with group B, the reduction in gingival index from baseline to 14 days was 31.95% and 38.62%, respectively, while from baseline to 21 days it was 69.95% and 68.57%, respectively. This difference was statistically not significant (Figure 2; Table 2). Intergroup comparison of group A and group B for gingival index (mean ± SD) at baseline to 14 days was 0.57 ± 0.069 and 0.73 ± 0.009, respectively, while from base line to 21 days it was 1.248 ± 0.108 and 1.296 ± 0.02, respectively (Table 3).

Figure 2.

Gingival index (GI) of group A versus group B.

Significant reduction in halitosis grading mean reported in both groups. The average grading at baseline was 5.4 ± 0.342 and 5.5 ± 0.453 for group A and group B, respectively, which reduced to 3.6 ± 0.125 and 3.4 ± 0.273 on the 14th day and further to 1.8 ± 0.542 and 1.5 ± 0.491 on the 21st day, respectively. Percentage reduction at 14th day from baseline was 33.33% and 38.18% for group A and group B, respectively. At 21 days from baseline, the reduction was 66.66% and 72.72%, respectively, for group A and group B (Table 5). Within group, there was significant reduction in halitosis for both groups from baseline to 14 days and 21 days. There was no statistical difference between the 2 groups for halitosis reduction (Figure 3; Table 5).

Table 5.

Halitosis Grading (Mean ± SD) for Both Groups at Various Time Intervals.

Time	Group A	Group B	P
Baseline	5.4 ± 0.342	5.5 ± 0.453	.351
14 days	3.6 ± 0.125	3.4 ± 0.273	.249
21 days	1.8 ± 0.542	1.5 ± 0.491	.079

Figure 3.

Halitosis grading of group A versus group B.

Discussion

The present study was designed to evaluate the effect of an herbal decoction in gingivitis, halitosis, and plaque inhibition. Till date there are limited studies on use of Triphala and Ela as mouth rinse to treat the aforementioned oral conditions.

Triphala has been used as decoction, powder, and in oil form to treat shitada or gingivitis in Sushruta Samhita, Chikitsa Sthan while describing treatment of mukh roga (diseases of mouth).¹¹ Various scientific studies on Triphala indicate its antimicrobial property and its growth inhibitory activities against common bacterial isolates.^12

–15 It has also been show to possess antioxidant properties, free radical scavenging, and thus is an appropriate formulation for further evaluation of its effect on plaque-induced gingivitis.^16,17

According to ayurveda, Triphala is tridoshahar, that is, vata, pitta, and kapha balancing in nature. Separately, Haritaki has been mentioned as tridoshahar. It has shothahar (anti-inflammatory), vranashodhan (wound cleansing), vedanasthapan (analgesic) actions, which are helpful for treating the inflammation of gingiva. Amalaki is also a tridoshhar. It is known as vedanasthapan (analgesic) that alleviates pain. It is a rich source of vitamin C, which is required for collagen maturation and is essential to maintain firm and healthy gingiva. Vibhitaki is also tridoshhar and apart from other beneficial actions it has vedanasthapan (analgesic) properties.¹¹ Ela churna was mixed with Triphala decoction to treat the bad odor of mouth as it is known as mukhashodhan and was found to have potential immunomodulatory action, and antimicrobial against dental caries–causing organisms.^18
–20 The earliest clinical trial on Triphala and its role in periodontal disease was conducted by Maurya et al,²¹ who studied effect of Triphala alone and as an adjunct to metronidazole in treatment of periodontal disease. It was concluded that the drug Triphala or metronidazole alone is capable of providing partial relief but when both are used in a combined form, they are more effective for the treatment of periodontal disease. Similar findings were concluded in a recent trial by Tripathi and Tiwari.²² The present study also showed effectiveness of Triphala in controlling plaque-induced gingivitis that is considered first stage of periodontal disease. An in vitro study by Prabhakar et al²³ reported that Triphala is efficient in inhibition of plaque biofilm and hence is effective in treating tooth biofilm infection. Similar outcomes were seen in present study where the plaque index improved for Triphla and Ela group at 14 and 21 days from baseline. And this improvement was similar to that of the chlorhexidine group.

A randomized trial conducted by Bajaj and Tandon²⁴ concluded that there is no difference between Triphala and chlorhexidine mouthwash on gingivitis and plaque formation. A concentration of 0.6% of Triphala was used against 0.1% chlorhexidine and both were efficient in controlling gingivitis and plaque biofilm formation. Also, it was seen that Triphala and chlorhexidine showed similar inhibitory effect on microbial counts, except lactobacillus, where Triphala has shown better results than chlorhexidine.²⁴

Similar concentration of Triphala was used in a study by Gupta et al,²⁵ wherein 0.6% Triphala was highly effective in preventing plaque accumulation and gingivitis as compared with 0.2% chlorhexidine mouth rinse.

Bhattacharjee et al²⁶ conducted a study on 57 schoolchildren and compared chlorhexidine and Triphala mouthwash. They concluded that the effectiveness of Triphala in the reduction of plaque and gingivitis was comparable to chlorhexidine and that Triphala can be used for short-term purposes without potential side effects.²⁶

In the present study, it was seen that Triphla and Ela group and chlorhexidine group reported similar effect on gingival index indicating that both the preparations were effective in controlling gingivitis and plaque buildup at 14 and 21 days.

None of the previous studies have evaluated improvement in halitosis grading for Triphala and Ela mouth rinse. Both groups reported reduction in halitosis and improvement in halitosis grading at 14 and 21 days compared with baseline grades.

Triphala has been recently reported to have an in vitro effect on drug modulating enzymes. Disturbance on cytochrome P450 is mentioned, thereby the likelihood of herb-drug interactions, if these are administered concomitantly, can be expected.²⁷ Hence care should be taken in patients under multiple drugs and more scientific relevant clinical evidence is required to advocate its use as a sole or adjunct therapy in controlling gingivitis, plaque build-up, and halitosis.

Conclusion

The present study shows that Triphala and Ela decoction has similar efficacy as that of chlorhexidine in reducing dental biofilm build-up, gingivitis, and halitosis. It is easy to prepare, organic, and relatively economical compared with chlorhexidine. Hence it can be used for effective plaque control, gingivitis control, and halitosis. Limitations of our study included small sample size and the inability to document long-term side effects, if any, of Triphala and Ela decoction. Further pharmacological studies are needed to assess for the drug interaction ability of Triphala and Ela and understand the possible drug interactions if any.

Footnotes

Author Contributions

PM contributed toward conception of design, preparation of Triphala & Ela mouthwash, interpretation of data, writing and review of manuscript. AK contributed toward conception of design, collection of dental data, gingival index and plaque index, interpretation of data, writing of manuscript, and responsibility of work. RKM contributed toward conception of design, preparation of Triphala Ela mouthwash, interpretation of data, writing, and review of manuscript.

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Ethical Approval

This study was approved by the ethical committee of Himalayan Institute of Medical Sciences (HIHTU/HIMS/RC/2013/307).

References

Samy

Pushparaj

Ponnampalam

. A compilation of bioactive compounds from Ayurveda. Bioinformation. 2008;3:100–110.

American Academy of Periodontology. Proceedings of the World Workshop in Clinical Periodontics. Chicago, IL: American Academy of Periodontology; 1989: I/23–I/24

Loe

Schiött

. The effect of mouthrinses and topical application of chlorhexidine on the development of dental plaque and gingivitis in man. J Peridontal Res. 1970;5:79–83.

Bhav Prakash. Churna Prakaran. Nagpur, India: Shri Vaidyanath Ayurveda Bhavan; 1978.

Sharma

. Dravya Guna Vigyan. Varanasi, India: Chaukhambha Bharti Academy; 1983.

Silness

Loe

. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand. 1964;22:121–135.

Loe

. The gingival index, the plaque index and the retention index systems. J Periodontol. 1967;38(suppl):610–616.

Miyazaki

Arao

Okamura

. Tentative classification of halitosis and its treatment needs [in Japanese]. Niigata Dent J. 1999;32:7–11.

World Medical Association. Declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–2194. doi:10.1001/jama.2013.281053.

10.

Sharma

, ed. Preparation methodology of Triphala Sushruta Samhita, Chikitsa Sthan, Chapter 22/10-12. Commentary by Dalhana. Varanasi, India: Chaukhambha Visvabharati; 200 8.

11.

Sarangadhar Samhita, Madhyam Khanda, Churna Kalpana. 5th ed. Chapter 6, verse 9-10, p 85. Varanasi, India: Chaukhambha Orientalia; 2003.

12.

Mehta

Shitut

Wankhade

. In vitro antimicrobialefficacy of Triphala. Fitoterapia. 1999;64:371–372.

13.

Thomas

Shetty

Vasudeva

Shetty

. Comparative evaluation of antimicrobial activity of Triphala and commercially available toothpastes: an in-vitro study. Int J Public Health Dent. 2011:2:8–12.

14.

Srinagesh

Krishnappa

Somanna

. Antibacterial efficacy of Triphala against oral streptococci: an in vivo study. Indian J Dent Res. 2012;23:696.

15.

Srikumar

Parthasarathy

Shankar

. Evaluation of the growth inhibitory activities of Triphala against common bacterial isolates from HIV-infected patients. Phytother Res. 2007;21:476–480.

16.

Vani

Rajani

Sarkar

Shishoo

. Antioxidant properties of the ayurvedic formulation Triphala and its constituents. Int J Pharmacognosy. 1997;35:313–317.

17.

Naik

Priyadarsini

Mohan

. Free radical scavenging reactions and phytochemical analysis of Triphala, an ayurvedic formulation. Curr Sci. 2006;90:1100–1105.

18.

Pandey

, ed. Bhavprakash Nighantu, Haritakyadi Varga. Commentary by Chunekar KV Varanasi, India: Chaukhambha Orientalia; 2002.

19.

Majdalawieh

Carr

. investigation of the potential immunomodulatory and anti-cancer activities of black pepper (Piper nigrum) and cardamom (Elettaria cardamomum). J Med Food. 2010;13:371–381.

20.

Aneja

Joshi

. Antimicrobial activity of Amomum subulatum and Elettaria cardamomum against dental caries causing microorganisms. Ethnobotanical Leaflets. 2009;2009(7):Article 3.

21.

Maurya

Miltal

Sharma

Nath

. Role of Triphala in management of periodontal disease. Anc Sci Life. 1997;17:120–127.

22.

Tripathi

Tiwari

. Use of herbal drugs in the management of periodontal disease. Int J Adv Res. 2015;3:608–614.

23.

Prabhakar

Senthilkumar

Priya

Mahalakshmi

Sehgal

Sukumaran

. Evaluation of antimicrobial efficacy of herbal alternatives (Triphala and green tea polyphenols), MTAD, and 5% sodium hypochlorite against Enterococcus faecalis biofilm formed on tooth substrate: an in vitro study. J Endod. 2010;36:83–86.

24.

Bajaj

Tandon

. The effect of Triphala and chlorhexidine mouthwash on dental plaque, gingival inflammation, and microbial growth. Int J Ayurveda Res. 2011;2:29–36.

25.

Gupta

Tandon

Rao

Malagi

. Effects of Triphala mouthwash on the oral health status. Malays Dent J. 2004;25:27–46.

26.

Bhattacharjee

Nekkanti

Kumar

Kapuria

Acharya

Pentapati

. Efficacy of Triphala mouth rinse (aqueous extracts) on dental plaque and gingivitis in children. J Invest Clin Dent. 2015;6:206–210.

27.

Ponnusankar

Pandit

Babu

Bandyopadhyay

Mukherjee

. Cytochrome P450 inhibitory potential of Triphala: a rasayana from ayurveda. J Ethnopharmacol. 2011;133:120–125.

Comparative Evaluation of Triphala and Ela Decoction With 0.2% Chlorhexidine as Mouthwash in the Treatment of Plaque-Induced Gingivitis and Halitosis: A Randomized Controlled Clinical Trial

Abstract

Aim.

Keywords

Subjects and Methods

Results

Plaque Index

Triphala and Ela: Group A

Chlorhexidine group: Group B

Gingival Index

Triphala and Ela Group: Group A

Chlorhexidine Group: Group B

Discussion

Conclusion

Footnotes

Author Contributions

Declaration of Conflicting Interests

Funding

Ethical Approval

References